Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Danaher Corp (DHR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 89,889,136
  • Shares Outstanding, K 701,875
  • Annual Sales, $ 19,893 M
  • Annual Income, $ 2,651 M
  • 60-Month Beta 1.04
  • Price/Sales 4.54
  • Price/Cash Flow 19.99
  • Price/Book 3.20

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 1.01
  • Number of Estimates 8
  • High Estimate 1.02
  • Low Estimate 0.98
  • Prior Year 0.99
  • Growth Rate Est. (year over year) +2.02%

Price Performance

See More
Period Period Low Period High Performance
1-Month
110.66 +16.38%
on 02/20/19
129.42 -0.49%
on 03/15/19
+17.47 (+15.69%)
since 02/19/19
3-Month
94.59 +36.16%
on 12/24/18
129.42 -0.49%
on 03/15/19
+28.14 (+27.96%)
since 12/19/18
52-Week
94.59 +36.16%
on 12/24/18
129.42 -0.49%
on 03/15/19
+28.48 (+28.39%)
since 03/19/18

Most Recent Stories

More News
UTX vs. DHR: Which Stock Should Value Investors Buy Now?

UTX vs. DHR: Which Stock Is the Better Value Option?

UTX : 127.64 (+0.58%)
DHR : 128.53 (+0.36%)
Danaher Corp Up 25.4% Since SmarTrend Uptrend Call (DHR)

SmarTrend identified an Uptrend for Danaher Corp (NYSE:DHR) on December 28th, 2018 at $102.21. In approximately 3 months, Danaher Corp has returned 25.36% as of today's recent price of $128.13.

DHR : 128.53 (+0.36%)
Danaher to Gain From Solid Demand in Key Markets Amid Risks

Effective implementation of Danaher Business System and solid demand for innovative products are likely to boost Danaher's (DHR) revenues.

MIC : 40.58 (-0.27%)
UTX : 127.64 (+0.58%)
CSL : 125.85 (+0.66%)
DHR : 128.53 (+0.36%)
Danaher Corp Set to Possibly Pullback After Yesterday's Rally of 1.26%

Danaher Corp (NYSE:DHR) traded in a range yesterday that spanned from a low of $125.69 to a high of $126.65. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $125.27...

DHR : 128.53 (+0.36%)
Danaher Announces Quarterly Dividend

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.17 per share payable on April 26, 2019 to holders of record on March 29,...

DHR : 128.53 (+0.36%)
21.3% Return Seen to Date on SmarTrend Danaher Corp Call (DHR)

SmarTrend identified an Uptrend for Danaher Corp (NYSE:DHR) on December 28th, 2018 at $102.21. In approximately 2 months, Danaher Corp has returned 21.29% as of today's recent price of $123.97.

DHR : 128.53 (+0.36%)
Report: Developing Opportunities within Sarepta Therapeutics, Sally Beauty, Danaher, Ellie Mae, BioCryst Pharmaceuticals, and Akcea Therapeutics -- Future Expectations, Projections Moving into 2019

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Sarepta Therapeutics, Inc. (NASDAQ:SRPT),...

ELLI : 98.76 (-0.18%)
SRPT : 125.45 (-1.08%)
AKCA : 29.70 (-1.39%)
SBH : 18.46 (+1.76%)
BCRX : 8.01 (-1.35%)
DHR : 128.53 (+0.36%)
Danaher's Stock Offering Proceeds to Fund BioPharma Buyout

Danaher (DHR) successfully completes the offering of common and preferred shares. It intends on using the funds raised to pay for the pending acquisition of General Electric's BioPharma business.

UTX : 127.64 (+0.58%)
CSL : 125.85 (+0.66%)
GE : 10.30 (+0.98%)
DHR : 128.53 (+0.36%)
Danaher Announces Closing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering

Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has closed concurrent offerings of 12,100,000 shares of common stock at a price to the public of $123.00 per share and 1,650,000 shares...

DHR : 128.53 (+0.36%)
Uptrend Call Working As Danaher Corp Stock Rises 23.7% (DHR)

SmarTrend identified an Uptrend for Danaher Corp (NYSE:DHR) on December 28th, 2018 at $102.21. In approximately 2 months, Danaher Corp has returned 23.66% as of today's recent price of $126.39.

DHR : 128.53 (+0.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade DHR with:

Business Summary

Danaher Corporation is a global science and technology innovator committed to helping customers solve complex challenges and improving quality of life around the world. It operates through the following business segments : Test & Measurement, Environmental, Life Sciences & Diagnostics, Dental and Industrial...

See More

Key Turning Points

2nd Resistance Point 130.05
1st Resistance Point 129.06
Last Price 128.53
1st Support Level 127.21
2nd Support Level 126.35

See More

52-Week High 129.42
Last Price 128.53
Fibonacci 61.8% 116.11
Fibonacci 50% 112.00
Fibonacci 38.2% 107.90
52-Week Low 94.59

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar